CAN THE CONTROVERSY OF THE ROLE OF ALUMINUM IN ALZHEIMER'S DISEASE BE RESOLVED? WHAT ARE THE SUGGESTED APPROACHES TO THIS CONTROVERSY AND METHODOLOGICAL ISSUES TO BE CONSIDERED?

Author： Savory John   Exley Christopher   Forbes William F.   Huang Yue   Joshi Jayant G.   Kruck Theo   Mclachlan Donald R. C.   Wakayama Ikuro  

Publisher： Taylor & Francis Ltd

ISSN： 1087-2620

Source： Journal of Toxicology and Environmental Health, Vol.48, Iss.6, 1996-08, pp. : 615-636

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The ezetimibe controversy – can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together?

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1469-1480

Informa Healthcare

Access to resources Recommend Favorite

Has the controversy over the use of calcium channel blockers in coronary artery disease been resolved?

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 5, 2005-05 ,pp. : 831-834

Informa Healthcare

Access to resources Recommend Favorite

Alzheimer Disease: What Role for Leptin and Insulin?

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 4, 2006-12 ,pp. : 271-279

Bentham Science Publishers

Access to resources Recommend Favorite

Guidelines for the Management of Lyme Disease: The Controversy and the Quandary

By Bowie William R.  

Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. : 2661-2666

Adis International

Access to resources Recommend Favorite

Statins and the risk of Parkinson disease: an update on the controversy

By Becker Claudia   Meier Christoph R  

Expert Opinion on Drug Safety, Vol. 8, Iss. 3, 2009-05 ,pp. : 261-271

Informa Healthcare

Access to resources Recommend Favorite